Related Experiment Video
Updated: Jun 27, 2025

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli
Published on: June 27, 2015
Activation of Pannexin-1 channels causes cell dysfunction and damage in mesangial cells derived from angiotensin
Claudia M Lucero1, Laura Navarro1, Cristián Barros-Osorio1
1Institute of Biomedical Sciences, Faculty of Health Sciences, Universidad Autónoma de Chile, Santiago, Chile.
Abstract:
Chronic kidney disease (CKD) is a prevalent health concern associated with various pathological conditions, including hypertensive nephropathy. Mesangial cells are crucial in maintaining glomerular function, yet their involvement in CKD pathogenesis remains poorly understood. Recent evidence indicates that overactivation of Pannexin-1 (Panx1) channels could contribute to the pathogenesis and progression of various diseases. Although Panx1 is expressed in the kidney, its contribution to the dysfunction of renal cells during pathological conditions remains to be elucidated. This study aimed to investigate the impact of Panx1 channels on mesangial cell function in the context of hypertensive nephropathy. Using an Ang II-infused mouse model and primary mesangial cell cultures, we demonstrated that in vivo exposure to Ang II sensitizes cultured mesangial cells to show increased alterations when they are subjected to subsequent in vitro exposure to Ang II. Particularly, mesangial cell cultures treated with Ang II showed elevated activity of Panx1 channels and increased release of ATP. The latter was associated with enhanced basal intracellular Ca2+ ([Ca2+]i) and increased ATP-mediated [Ca2+]i responses. These effects were accompanied by increased lipid peroxidation and reduced cell viability. Crucially, all the adverse impacts evoked by Ang II were prevented by the blockade of Panx1 channels, underscoring their critical role in mediating cellular dysfunction in mesangial cells. By elucidating the mechanisms by which Ang II negatively impacts mesangial cell function, this study provides valuable insights into the pathogenesis of renal damage in hypertensive nephropathy.
Insights
Pannexin-1 (Panx1) channels contribute to kidney damage in hypertensive nephropathy by impairing mesangial cell function. Blocking Panx1 channels protects these vital renal cells, offering a potential therapeutic target for hypertension-related kidney disease.
Area of Science:
- Nephrology
- Cell Biology
- Pathophysiology
Background:
- Chronic kidney disease (CKD) is a widespread condition linked to hypertensive nephropathy.
- Mesangial cell dysfunction is implicated in CKD, but the underlying mechanisms are unclear.
- Pannexin-1 (Panx1) channels are increasingly recognized for their role in disease pathogenesis.
Purpose of the Study:
- To investigate the role of Panx1 channels in mesangial cell dysfunction during hypertensive nephropathy.
- To elucidate the impact of Angiotensin II (Ang II) on mesangial cells via Panx1.
Main Methods:
- Utilized an Ang II-infused mouse model and primary mesangial cell cultures.
- Assessed Panx1 channel activity, ATP release, intracellular calcium ([Ca2+]i) levels, lipid peroxidation, and cell viability.
- Employed Panx1 channel blockade to evaluate its protective effects.
Main Results:
- Ang II exposure increased Panx1 activity and ATP release in mesangial cells.
- Elevated ATP levels led to enhanced basal and stimulated [Ca2+]i responses.
- These effects correlated with increased lipid peroxidation and decreased cell viability.
- Panx1 channel blockade abrogated Ang II-induced mesangial cell damage.
Conclusions:
- Panx1 channels mediate Ang II-induced mesangial cell dysfunction in hypertensive nephropathy.
- Targeting Panx1 channels may offer a therapeutic strategy for preventing renal damage in hypertension.
- This study provides crucial insights into the mechanisms of renal injury in hypertensive nephropathy.
More Related Videos
07:21Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors